NOS2, nitric oxide synthase 2, 4843

N. diseases: 783; N. variants: 28
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.540 AlteredExpression phenotype BEFREE Consumption of a HFD for 14 weeks caused intestinal permeabilization and endotoxemia, which were associated with a decreased ileum expression of tight junction (TJ) proteins (occludin, ZO-1 and claudin-1), increased expression of NADPH oxidase (NOX1 and NOX4) and NOS2 and oxidative stress, and activation of redox sensitive signals (NF-κB and ERK1/2) that regulate TJ dynamics. 31330482 2019
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.540 Biomarker phenotype BEFREE Experimental endotoxemia <i>in vivo</i> or <i>in vitro</i> induced iNOS protein and mtROS production. 31772705 2019
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.540 AlteredExpression phenotype BEFREE Pretreatment with berberine reduced LPS-induced iNOS protein expression and the cytoplasmic translocation of HuR in liver tissues and increased the survival rate of mice with LPS-induced endotoxemia. 27189969 2016
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.540 Biomarker phenotype RGD Beneficial effects of magnolol in a rodent model of endotoxin shock. 20519137 2010
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.540 Biomarker phenotype RGD In this study, we examined changes in gene expression of iNOS in various regions of the intestine as well as the distribution of iNOS protein in the intestinal cells in a rat model of endotoxemia produced by intraperitoneal injection of lipopolysaccharide (LPS; 10 mg/kg). 16787348 2005
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.540 Biomarker phenotype BEFREE In addition to protecting mice against lethal endotoxemia, SUN C8079 prevented the development of myocarditis due to the encephalomyocarditis virus (EMCV), and inhibited the expressions of proinflammatory cytokines and the iNOS gene in cardiac tissues. 14984720 2004
CUI: C0376618
Disease: Endotoxemia
Endotoxemia
0.540 Biomarker phenotype CTD_human Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. 12620498 2003